- Home
- DRTS vs DHY Comparison
DRTS vs DHY Comparison
Compare DRTS & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- DHY
- Stock Information
- Founded
- DRTS 2015
- DHY 1998
- Country
- DRTS Israel
- DHY United States
- Employees
- DRTS N/A
- DHY N/A
- Industry
- DRTS Medical/Dental Instruments
- DHY Finance/Investors Services
- Sector
- DRTS Health Care
- DHY Finance
- Exchange
- DRTS Nasdaq
- DHY Nasdaq
- Market Cap
- DRTS 211.7M
- DHY 218.7M
- IPO Year
- DRTS N/A
- DHY N/A
- Fundamental
- Price
- DRTS $2.62
- DHY $2.11
- Analyst Decision
- DRTS Strong Buy
- DHY
- Analyst Count
- DRTS 2
- DHY 0
- Target Price
- DRTS $8.00
- DHY N/A
- AVG Volume (30 Days)
- DRTS 68.0K
- DHY 569.1K
- Earning Date
- DRTS 03-12-2025
- DHY 01-01-0001
- Dividend Yield
- DRTS N/A
- DHY 9.10%
- EPS Growth
- DRTS N/A
- DHY N/A
- EPS
- DRTS N/A
- DHY N/A
- Revenue
- DRTS N/A
- DHY N/A
- Revenue This Year
- DRTS N/A
- DHY N/A
- Revenue Next Year
- DRTS N/A
- DHY N/A
- P/E Ratio
- DRTS N/A
- DHY N/A
- Revenue Growth
- DRTS N/A
- DHY N/A
- 52 Week Low
- DRTS $1.75
- DHY $1.77
- 52 Week High
- DRTS $4.39
- DHY $2.08
- Technical
- Relative Strength Index (RSI)
- DRTS 37.08
- DHY 36.59
- Support Level
- DRTS $2.59
- DHY $2.13
- Resistance Level
- DRTS $2.73
- DHY $2.18
- Average True Range (ATR)
- DRTS 0.20
- DHY 0.02
- MACD
- DRTS -0.01
- DHY -0.00
- Stochastic Oscillator
- DRTS 23.53
- DHY 2.86
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.